Atypical Spitz tumours and sentinel lymph node biopsy: A systematic review

The Lancet Oncology

Volumn 15, Issue 4, 2014, Pages

  Lallas, Aimilios ^a   Kyrgidis, Athanassios ^b   Ferrara, Gerardo ^c   Kittler, Harald ^d   Apalla, Zoe ^e   Castagnetti, Fabio ^a   Longo, Caterina ^a   Moscarella, Elvira ^a   Piana, Simonetta ^a   Zalaudek, Iris ^a,f   Argenziano, Giuseppe ^a  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c G RUMMO HOSPITAL   (Italy)

^d Universitatsklinik fur Dermatologie   (Austria)

^e Hospital of Skin and Venereal Diseases   (Greece)

^f Universitatsklinik fur Dermatologie und Venerologie   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PROGNOSIS; CANCER SURVIVAL; DISEASE ASSOCIATION; HUMAN; JUVENILE MELANOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; PATIENT CARE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; SURVIVAL PREDICTION; SYSTEMATIC REVIEW;

HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEVUS, EPITHELIOID AND SPINDLE CELL; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 84897087251     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(13)70608-9     Document Type: Review

References (53)

1. Spitz S Melanomas of childhood. Am J Pathol 1948, 24:591-609.
2. Kernen JA, Ackerman LV Spindle cell nevi and epithelioid cell nevi (so-called juvenile melanomas) in children and adults: a clinicopathological study of 27 cases. Cancer 1960, 13:612-625.
3. Smith KJ, Barrett TL, Skelton HG, Lupton GP, Graham JH Spindle cell and epithelioid cell nevi with atypia and metastasis (malignant Spitz nevus). Am J Surg Pathol 1989, 13:931-939.
4. Barnhill RL, Flotte TJ, Fleischli M, Perez-Atayde A Cutaneous melanoma and atypical Spitz tumors in childhood. Cancer 1995, 76:1833-1845.
5. Barnhill RL, Argenyi ZB, From L, et al. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol 1999, 30:513-520.
6. Elder DE, Xu X The approach to the patient with a difficult melanocytic lesion. Pathology 2004, 36:428-434.
7. Zembowicz A, Scolyer RA Nevus/melanocytoma/melanoma: an emerging paradigm for classification of melanocytic neoplasms?. Arch Pathol Lab Med 2011, 135:300-306.
8. Kelley SW, Cockerell CJ Sentinel lymph node biopsy as an adjunct to management of histologically difficult to diagnose melanocytic lesions: a proposal. J Am Acad Dermatol 2000, 42:527-530.
9. Leboit PE What do these cells prove?. Am J Dermatopathol 2003, 25:355-356.
10. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses (accessed Feb 18, 2014). http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
11. Gerami P, Scolyer RA, Xu X, et al. Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations. Am J Surg Pathol 2013, 37:676-684.
12. Lohmann CM, Coit DG, Brady MS, Berwick M, Busam KJ Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors. Am J Surg Pathol 2002, 26:47-55.
13. Su LD, Fullen DR, Sondak VK, Johnson TM, Lowe L Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients. Cancer 2003, 97:499-507.
14. Roaten JB, Partrick DA, Pearlman N, Gonzalez RJ, Gonzalez R, McCarter MD Sentinel lymph node biopsy for melanoma and other melanocytic tumors in adolescents. J Pediatr Surg 2005, 40:232-235.
15. Gamblin TC, Edington H, Kirkwood JM, Rao UNM Sentinel lymph node biopsy for atypical melanocytic lesions with spitzoid features. Ann Surg Oncol 2006, 13:1664-1670.
16. Murali R, Sharma RN, Thompson JF, et al. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors). Ann Surg Oncol 2008, 15:302-309.
17. Ludgate MW, Fullen DR, Lee J, et al. The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution. Cancer 2009, 115:631-641.
18. Busam KJ, Murali R, Pulitzer M, et al. Atypical spitzoid melanocytic tumors with positive sentinel lymph nodes in children and teenagers, and comparison with histologically unambiguous and lethal melanomas. Am J Surg Pathol 2009, 33:1386-1395.
19. Berk DR, LaBuz E, Dadras SS, Johnson DL, Swetter SM Melanoma and melanocytic tumors of uncertain malignant potential in children, adolescents and young adults-the Stanford experience 1995-2008. Pediatr Dermatol 2010, 27:244-254.
20. Ghazi B, Carlson GW, Murray DR, et al. Utility of lymph node assessment for atypical spitzoid melanocytic neoplasms. Ann Surg Oncol 2010, 17:2471-2475.
21. Cerroni L, Barnhill R, Elder D, et al. Melanocytic tumors of uncertain malignant potential: results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008. Am J Surg Pathol 2010, 34:314-326.
22. Sepehr A, Chao E, Trefrey B, et al. Long-term outcome of Spitz-type melanocytic tumors. Arch Dermatol 2011, 147:1173-1179.
23. Barnhill RL, Kutzner H, Schmidt B, et al. Atypical spitzoid melanocytic neoplasms with angiotropism: a potential mechanism of locoregional involvement. Am J Dermatopathol 2011, 33:236-243.
24. Caracò C, Mozzillo N, Di Monta G, et al. Sentinel lymph node biopsy in atypical Spitz nevi: is it useful?. Eur J Surg Oncol 2012, 38:932-935.
25. Cerrato F, Wallins JS, Webb ML, McCarty ER, Schmidt BA, Labow BI Outcomes in pediatric atypical spitz tumors treated without sentinel lymph node biopsy. Pediatr Dermatol 2012, 29:448-453.
26. Hung T, Piris A, Lobo A, et al. Sentinel lymph node metastasis is not predictive of poor outcome in patients with problematic spitzoid melanocytic tumors. Hum Pathol 2013, 44:87-94.
27. Urso C, Borgognoni L, Saieva C, et al. Sentinel lymph node biopsy in patients with 'atypical Spitz tumors.' A report on 12 cases. Hum Pathol 2006, 37:816-823.
28. Magro CM, Crowson AN, Mihm MC, Gupta K, Walker MJ, Solomon G The dermal-based borderline melanocytic tumor: a categorical approach. J Am Acad Dermatol 2010, 62:469-479.
29. Massi D, Cesinaro AM, Tomasini C, et al. Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis. J Am Acad Dermatol 2011, 64:919-935.
30. McArthur GJ, Banwell ME, Cook MG, Powell BW The role of sentinel node biopsy in the management of melanocytic lesions of uncertain malignant potential (MUMP). J Plast Reconstr Aesthet Surg 2007, 60:952-954.
31. Urso C, Borgognoni L, Doria M, Tinacci G, Zini E Non-sentinel lymph node involvement in a patient with an atypical Spitz tumor and a positive sentinel node. Report of a case and review of the literature. J Cutan Pathol 2009, 36:586-590.
32. Ahmadi N, Davison SP, Kauffman CL Melanocytic nevi with Spitz differentiation: diagnosis and management. Laryngoscope 2010, 120:2385-2390.
33. Pennacchia I, Gasbarra R, Manente L, et al. Polypoid Spitz nevus: two cases evaluated with genetic technique, prolonged follow up, and sentinel lymph node biopsy. J Cutan Pathol 2011, 38:747-752.
34. Lazzeri D, Pieroni M, De Rosa M, Agostini T Atypical Spitz tumour with positive sentinel lymph node. J Plast Surg Hand Surg 2013, 47:234-237.
35. Gerami P, Cooper C, Bajaj S, et al. Outcomes of atypical Spitz tumors with chromosomal copy number aberrations and conventional melanomas in children. Am J Surg Pathol 2013, 37:1387-1394.
36. Shen L, Cooper C, Bajaj S, et al. Atypical Spitz tumors with 6q23 deletions: a clinical, histological, and molecular study. Am J Dermatopathol 2013, 35:804-812.
37. Conti EM, Cercato MC, Gatta G, Ramazzotti V, Roscioni S Childhood melanoma in Europe since 1978: a population-based survival study. Eur J Cancer 2001, 37:780-784. EUROCARE Working Group.
38. Pappo AS Melanoma in children and adolescents. Eur J Cancer 2003, 39:2651-2661.
39. Strouse JJ, Fears TR, Tucker MA, Wayne AS Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol 2005, 23:4735-4741.
40. Wick MR Melanocytic lesions with features of Spitz nevus. Hum Pathol 2006, 37:779-780.
41. Cordoro KM, Gupta D, Frieden IJ, McCalmont T, Kashani-Sabet M Pediatric melanoma: results of a large cohort study and proposal for modified ABCD detection criteria for children. J Am Acad Dermatol 2013, 68:913-925.
42. Lange JR, Palis BE, Chang DC, Soong S-J, Balch CM Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base. J Clin Oncol 2007, 25:1363-1368.
43. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006, 355:1307-1317.
44. Meyers MO, Yeh JJ, Deal AM, et al. Age and Breslow depth are associated with a positive sentinel lymph node in patients with cutaneous melanocytic tumors of uncertain malignant potential. J Am Coll Surg 2010, 211:744-748.
45. Biddle DA, Evans HL, Kemp BL, et al. Intraparenchymal nevus cell aggregates in lymph nodes: a possible diagnostic pitfall with malignant melanoma and carcinoma. Am J Surg Pathol 2003, 27:673-681.
46. Holt JB, Sangueza OP, Levine EA, et al. Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi. Am J Clin Pathol 2004, 121:58-63.
47. Balch CM, Gershenwald JE, Soong S-J, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009, 27:6199-6206.
48. Coit DG, Andtbacka R, Anker CJ, et al. Melanoma. J Natl Compr Canc Netw 2012, 10:366-400.
49. Chao C, Martin RCG, Ross MI, et al. Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol 2004, 11:259-264.
50. Sondak VK, Taylor JMG, Sabel MS, et al. Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol 2004, 11:247-258.
51. Paek SC, Griffith KA, Johnson TM, et al. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma. Cancer 2007, 109:100-108.
52. Gammon B, Gerami P Fluorescence in situ hybridization for ambiguous melanocytic tumors. Histol Histopathol 2012, 27:1539-1542.
53. Vergier B, Prochazkova-Carlotti M, de la Fouchardière A, et al. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases. Mod Pathol 2011, 24:613-623.